Brief: Pharmather Sells Ketamine ANDA, Eyes Over $25M In Milestone And Profit-Sharing Payments
01/10/2025 14:45
Oct 1 (Reuters) - Pharmather Holdings Ltd PHRM.CD: PHARMATHER ANNOUNCES SALE OF KETAMINE ANDA WITH POTENTIAL TO GENERATE OVER US$25 MILLION IN MILESTONE AND PROFIT-SHARING PAYMENTS Source text: ID:nGNX7dyQCH Further company coverage: PHRM.CD ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pharmather Holdings
See all newsBrief: Pharmather Sells Ketamine ANDA, Eyes Over $25M In Milestone And Profit-Sharing Payments
Brief: Pharmather receives US FDA approval goal date for Ketamine
Brief: Pharmather Announces Update On FDA New Drug Application For Ketamine
Brief: PharmTther Announces Post Complete Response Letter Clarification Meeting Request Granted From The FDA For Ketamine Abbreviated New Drug Application
Brief: Pharmather Receives Complete Response Letter From The U.S. Food And Drug Administration For Ketamine Abbreviated New Drug Application